SOLICITATION NOTICE
65 -- Agilent Technologies/ Various Assay kits and reagents.
- Notice Date
- 5/12/2022 12:22:51 PM
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH - CC BETHESDA MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 22-007429
- Response Due
- 5/19/2022 12:00:00 PM
- Point of Contact
- Grace Wong-Darko, Phone: 3014961199
- E-Mail Address
-
Grace.Wong-Darko@nih.gov
(Grace.Wong-Darko@nih.gov)
- Description
- INTRODUCTION This is not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Center for Cellular Engineering (CCE), Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (including brand-name) to: Agilent Technologies, INC 2850 Centerville RD Wilmington, DE 19808-1610, United States NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 325413 with a Size Standard 1,250. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2022-04 January 30, 2022. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold. STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title: Agilent/ Various Assay kits and reagents. 2. Background Information:� The Center for Cell Engineering (CCE), a part of Clinical Center is responsible for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy and gene therapy conducted in the Clinical Center at the NIH. Cell processing procedures are tailored to each of the 30 or more different patient-care clinical research protocols supported. Also, regarding Institute research support it. We will perform cell metabolic analysis of CAR-T cell and other type of engineered cell products which manufactured at CCE to create standard parameters and monitor cell viability and metabolic environment to ensure the cell growth in health condition and cell product pass QC for clinical sample of lot release. The Seahorse XFe96 FluxPak, XF real-time ATP rate assay kit, Seahorse XF Cell Mito Stress Test Kit, and Seahorse XF Glycolytic Rate Assay Kit with their media quantify the rate of ATP production from glycolysis and mitochondrial simultaneously, assesses mitochondrial function and measures the capacity of the glycolytic pathway after glucose starvation using label- free technology in live cells. 3. Purpose or Objective: The purpose of acquiring seahorse kits and reagents is to perform cell metabolic analysis of CAR-T cell and other type of engineered cell products which manufactured at CCE to create standard parameters and monitor cell viability and metabolic environment to ensure the cell growth in health condition and cell product pass QC for clinical sample of lot release. 4. Contract Duration:� 6/1/2022 � 5/30/2023. 5. CONTRACTOR REQUIREMENTS SCOPE: i.The contractor will supply quantity of 2 assay kits/reagents and disposables per catalog to process every two months according to the scheduled date below. Delivery Date: 6/1/22, 8/1/22, 10/3/22, 12/1/22, 2/1/23, and 4/1/23.� Cat#��� ������ Total QTY. ��Description� ����������������������������������� ����� 103729-100���� 12������ ��� Seahorse XFe96 FluxPak mini (PDL plates) � 103576-100��� 12������� ���� Seahorse XF RPMI medium, pH 7.4, 500mL 103592-100��� 12������� ���� Seahorse XF Real-Time ATP Rate Assay Kit 103015-100��� 12������� ���� Seahorse XF Cell Mito Stress Test Kit 103344-100��� 12������� ���� Seahorse XF Glycolytic Rate Assay Kit ii. Shelf Life-Minimum - shelf life of any unopened reagent shall be at least 60 days unless otherwise agreed to from date of delivery at the CCE PACT Laboratory. Shelf life of disposables shall be at least 3 months from date of delivery at the CCE PACT Laboratory 6. Inspections and Acceptance Requirements The contractor shall bear the cost of replacement for reagents and disposables found to be damaged or defective upon receipt by NIH or for incorrect or incomplete shipments. Michaela Prochazkova from the CC CCE PACT section will ����������� Receive reagents and kits under the appropriate conditions ����������� That the packaging integrity is not compromised ����������� That all ordered materials have arrived ����������� That serial numbers match the documentation ����������� Any discrepancies are reported to Service Chief and Agilent Logistical Requirements All materials will be delivered to: �CCE PACT NIH/CC �10 Center Drive � Bldg. 10/ Rm. 3C731 � Bethesda, MD 20892-1288 � Attention: Michaela Prochazkova Deliveries are 9 AM to 5:30 PM and must be signed for All packaging must be intact and a packing slip with serial numbers and certificates of analysis or conformance must be supplied along with any calibration certificates and operational software Government Responsibilities The Center for Cellular Engineering (CCE) shall use the reagents and disposables in accordance with manufacturer�s package inserts and approved IND/IDE uses if applicable. The NIH CC Center for Cellular Engineering (CCE) shall inspect shipments upon receipt and report any damage, defects or errors in shipment to the contractor.� CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME) DETERMINATION This system is on site and has been validated for use on CC patients.� It would be detrimental to the government to attempt to change systems and quite impossible as these instruments are proprietary and only distributed by Agilent Technologies Inc� With the continuation of using the same supplies will also help reduces the risk of a disruption in patient care. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, and the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. � A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by May 19th, 2022, 3:00 PM Eastern time and must reference solicitation number 22-007429. Responses may be submitted electronically to Mrs. Grace Wong-Darko, Contracting Specialist at Grace.Wong-Darko@nih.gov. Fax responses will not be accepted. ""All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.""
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/e3b6131fd45b4d638714fd72528d6b72/view)
- Place of Performance
- Address: Wilmington, DE 19808, USA
- Zip Code: 19808
- Country: USA
- Zip Code: 19808
- Record
- SN06325927-F 20220514/220512230108 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |